DTE

32.54

-2.66%↓

IBE

19.72

-1.33%↓

RWE

57.9

-0.96%↓

ELE

35.41

-1.2%↓

FORTUM.FI

22.21

+0.05%↑

DTE

32.54

-2.66%↓

IBE

19.72

-1.33%↓

RWE

57.9

-0.96%↓

ELE

35.41

-1.2%↓

FORTUM.FI

22.21

+0.05%↑

DTE

32.54

-2.66%↓

IBE

19.72

-1.33%↓

RWE

57.9

-0.96%↓

ELE

35.41

-1.2%↓

FORTUM.FI

22.21

+0.05%↑

DTE

32.54

-2.66%↓

IBE

19.72

-1.33%↓

RWE

57.9

-0.96%↓

ELE

35.41

-1.2%↓

FORTUM.FI

22.21

+0.05%↑

DTE

32.54

-2.66%↓

IBE

19.72

-1.33%↓

RWE

57.9

-0.96%↓

ELE

35.41

-1.2%↓

FORTUM.FI

22.21

+0.05%↑

Kodu・Aktsiate loetelu・STRATEC Biomedical AG

STRATEC Biomedical AG

Suletud

19.12 0.31

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

18.24

Max

19.68

Põhinäitajad
By Trading Economics
Sissetulek	200K 1.5M
Müük	-2.3M 57M
P/E Sektori keskmine	14.961 27.098
Aktsiakasum	0.124
Dividenditootlus	3.18
Kasumimarginaal	2.633
Töötajad	1,420
EBITDA	487K 8M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+55.18% upside

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	3.18% 2.99%
Järgmine tulemuste avaldamine	18. mai 2026

Turustatistika
By TradingEconomics
Turukapital	-70M 231M
Eelmine avamishind	18.81
Eelmine sulgemishind	19.12

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

N/A / 24.5 Toetus ja vastupanu

STRATEC Biomedical AG Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

8. juuli 2025, 17:24 UTC

Market Talk

Election, Dollar Seen as Potential Headwinds for Ibovespa -- Market Talk

Võrdlus sarnastega

Hinnamuutus

STRATEC Biomedical AG Prognoos

Hinnasiht

By TipRanks

55.18% tõus

12 kuu keskmine prognoos

Keskmine 29.67 EUR 55.18%

Kõrge 34 EUR

Madal 26 EUR

Põhineb 3 Wall Streeti analüütiku instrumendi STRATEC Biomedical AG 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

3 ratings

Osta

Hoia

Müü

Põhineb 3 analüütiku instrumendi STRATEC Biomedical AG aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

N/A / 24.5Toetus ja vastupanu

Recent bearish events outweigh bullish events.

All events are bearish.

There are no events.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest STRATEC Biomedical AG

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.